Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.

Amgen (NASDAQ:AMGN) today announced full results from Part 1 of the Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133), a long-acting, peptide-antibody conjugate subcutaneously ...

Kelsey Sharma, a nurse practitioner based in Minnesota, presents her research on the relationship between OSA, GERD, and IBD ...

Happy Health has announced that the U.S. Food and Drug Administration has cleared the Happy Ring as a class II medical device to facilitate the diagnosis of obstructive sleep apnea, insomnia and other ...

And the severe cases — when people stop breathing more than 30 times in a single hour — go up, too. "You also increase the ...

Southern California Pulmonary & Sleep Disorders Medical Center (805-557-9930) has announced the availability of the ...

At Home Sleep Apnea Testing launched WatchPAT One, a home-based sleep monitoring device for California residents. The ...

Over 104 million Indians suffer from obstructive sleep apnea, a common condition causing loud snores. This disorder has a ...

A personal crossword that should be less difficult to solve than my recent diagnosis.

Lake Cumberland Regional Hospital (LCRH) is proud to announce a major milestone in sleep apnea treatment, as Dr. Andrew ...

The many bizarre myths surrounding sleepwalking have overtaken scientific evidence. Here's your guide to truly understanding ...

The cannabinoid industry is transitioning from early-stage exploration to scientifically validated, regulatory-backed ...